Part VII • Aesthetic Surgery

Chapter 127: Noninvasive Body Contouring

Questions: 10
Answered: 0/10
Score: 0%
1 2 3 4 5 6 7 8 9 10
Question 1 of 10 NONINVASIVE BODY CONTOURING
In general, what is the greatest challenge of using noninvasive body contouring treatments?
A
The high treatment cost
B
The extended downtime
C
The subtle effects of treatment
D
The level of technical skills required
E
The need for multiple treatments
āœ“ Correct Answer: E. The need for multiple treatments
Clinical Explanation

Interest in noninvasive body contouring is growing due to the fact that it is effective, affordable, has a short downtime, and is easy to perform. In the United states, in almost three quarters of a million such treatments were delivered during 2018.1 The main caveat is that multiple treatments are often required. The requirement for timing and number of treatments differs according to the specific treatment modality and the desired effects. It is important to ensure patients understand the limitations of these treatments and that they may well need repeating.

References:
  • 1. American Society of Plastic Surgeons. National Clearinghouse of Plastic Surgery Statistics: 2019 Report of the 2018
  • Statistics. Arlington Heights, IL: American Society of Plastic Surgeons; 2019
Question 2 of 10 NONINVASIVE TREATMENTS FOR FAT REDUCTION
Which one of the following is true regarding noninvasive treatments for fat reduction and body contouring?
A
There are two main therapy types currently licensed for use.
B
Their clinical effectiveness is somewhat inconsistent.
C
Each treatment modality works by causing thermal changes to fat cells.
D
Patient satisfaction following such treatments tends to be very high.
E
Treatments represent an ideal alternative to traditional weight loss.
āœ“ Correct Answer: D. Patient satisfaction following such treatments tends to be very high.
Clinical Explanation

Noninvasive treatments for fat reduction have been shown to be effective and are associated with high rates of patient satisfaction. There are three (not two) main types of noninvasive treatment for fat reduction: cryolipolysis, high-intensity focused ultrasound (HIFU), and low-level laser therapy (LLLT). Each has a different mechanism of action and their own individual nuances. Only high-intensity ultrasound works by heating the fat cells to cause damage to them. Noninvasive treatments may be a reasonable alternative to surgical interventions such as liposuction, but they do not represent alternatives to weight loss, which should be encouraged in overweight patients.1,2

References:
  • 1. Krueger N, Mai SV, Luebberding S, Sadick NS. Cryolipolysis for noninvasive body contouring: clinical efficacy and patient
  • satisfaction. Clin Cosmet Investig Dermatol 2014;7(7):201–205
  • 2. Dierickx CC, Mazer JM, Sand M, Koenig S, Arigon V. Safety, tolerance, and patient satisfaction with noninvasive cryolip-
  • olysis. Dermatol Surg 2013;39(8):1209–1216
Question 3 of 10 CRYOTHERMOLIPOLYSIS
When undergoing cryolipolysis, which one of the following are patients most likely to experience?
A
Significant discomfort during treatment
B
Significant discomfort after treatment
C
Temporary erythema to the treated areas
D
Decreased light touch sensitivity to the treated areas
E
Temperature sensitivity to the treated areas
āœ“ Correct Answer: C. Temporary erythema to the treated areas
Clinical Explanation

Cryolipolysis is a treatment used to reduce fat cells in localized areas of adipose tissue such as the flanks, thighs, abdomen, and neck. The technique involves first marking the areas for treatment and then applying conduction gel to these areas. A cooling applicator is then attached to the skin with a mild vacuum device that has either one or two panels. Tissue is drawn into the cooling panel and treatment is delivered for 30 to 60 minutes. Patients need to understand the process in advance of the treatment and the symptoms they will experience. Erythema posttreatment with cryolipolysis is a very consistent finding and patients must be aware of this. It resolves spontaneously over 7 days. Many patients are likely to also experience minor discomfort during treatment and then go on to experience 2 to 3 days of edema to the treated areas. The pain they experience is usually well controlled with simple topical and oral analgesics. In addition, patients often experience decreased light touch sensitivity and temperature sensitivity to the treated areas after treatment. This completely resolves spontaneously within 8 weeks of treatment. Patients should also understand the potential for undercorrection or overcorrection of fat areas, possible contour irregularities, and undesirable overlying skin changes. As with many interventions, there is no guarantee of a specific aesthetic outcome.1–3

References:
  • 1. Manstein D, Laubach H, Watanabe K, Farinelli W, Zurakowski D, Anderson RR. Selective cryolysis: a novel method of
  • non-invasive fat removal. Lasers Surg Med 2008;40(9):595–604
  • 2. Coleman SR, Sachdeva K, Egbert BM, Preciado J, Allison J. Clinical efficacy of noninvasive cryolipolysis and its effects on
  • peripheral nerves. Aesthetic Plast Surg 2009;33(4):482–488
  • 3. Karcher C, Katz B, Sadick N. Paradoxical hyperplasia post-cryolipolysis and management. Dermatol Surg 2017;43(3):467–
Question 4 of 10 CRYOTHERMOLIPOLYSIS
When considering the evidence base underpinning cryolipolysis, which one of the following is true?
A
The precise mechanism of action is well understood.
B
Initial animal studies were ineffective at reducing fat volume.
C
Initial clinical studies were ineffective at reducing fat volume.
D
A systematic review has shown fat reduction as high as 28%.
E
Evidence has shown that multiple treatments are required.
āœ“ Correct Answer: D. A systematic review has shown fat reduction as high as 28%.
Clinical Explanation

Cryolipolysis is a noninvasive treatment used to reduce fat volumes in specific body areas such as the arms, bra line, back, abdomen, flank, banana roll, and thighs. There is a large volume of evidence to support its use. For example, a systematic review of cryolipolysis treatment in 2015 showed average reductions in caliper measurement of subcutaneous tissues as high as 28.5% (range: 14.7–28.5%).1 This evidence supports the clinical effectiveness of this treatment. Another study reviewed results in 53 patients in whom a single cryolipolysis treatment was delivered to the saddlebags. At 6 months posttreatment, mean thigh circumference had decreased 5.6 cm and the mean decrease in fat layer thickness measured by ultrasound was 1.3 cm. Patient satisfaction was also high (94% satisfaction rate).2 The precise mechanism of action by which cryolipolysis works is not well understood; however, it is theorized to be related to apoptosis-mediated cell death and subsequent inflammatory response or through cold-induced thermogenesis.3,4 Preclinical animal studies showed a 33% reduction in thickness of the superficial fat layer with maximal relative loss of nearly 80% with a single treatment.3 Although it is generally accepted that multiple treatments are required with noninvasive body contouring techniques, these data show that with cryolipolysis, single-treatment delivery can achieve beneficial effects.

References:
  • 1. Ingargiola MJ, Motakef S, Chung MT, Vasconez HC, Sasaki GH. Cryolipolysis for fat reduction and body contouring: safety
  • and efficacy of current treatment paradigms. Plast Reconstr Surg 2015;135(6):1581–1590
  • 2. Adjadj L, SidAhmed-Mezi M, Mondoloni M, Meningaud JP, Hersant B. Assessment of the efficacy of cryolipolysis on
  • saddlebags: a prospective study of 53 patients. Plast Reconstr Surg 2017;140(1):50–57
  • 3. Zelickson B, Egbert BM, Preciado J, et al. Cryolipolysis for noninvasive fat cell destruction: initial results from a pig model.
  • Dermatol Surg 2009;35(10):1462–1470
  • 4. Loap S, Lathe R. Mechanism underlying tissue cryotherapy to combat obesity/overweight: triggering thermogenesis.
  • J Obes 2018 (epub ahead of print) doi: 10.1155/2018/5789647
Question 5 of 10 HIGH-INTENSITY FOCUSED ULTRASOUND FOR FAT REDUCTION
A patient is planning to undergo HIFU treatment to reduce excess abdominal fat. Which one of the following represents the proposed mechanism of action for this treatment modality?
A
Coagulative necrosis
B
Apoptosis
C
Cold-induced thermogenesis
D
Nonthermal cellular injury
E
Mechanical emptying of fat cells
āœ“ Correct Answer: A. Coagulative necrosis
Clinical Explanation

HIFU is a noninvasive treatment used to reduce fat in specific body areas. It uses focused energy to thermally ablate subcutaneous adipose tissue and to induce neocollagenesis. HIFU increases the local temperature within the mid-lamellar fat layer leading to coagulative necrosis of adipocytes and subsequent reduction of fat layer.1 Apoptosis is programmed cell death and is believed to be one potential mechanism of action for cryolipolysis, a treatment that cools the subcutaneous tissues. The other proposed mechanism for cryolipolysis is cold-induced thermogenesis. Low-level laser energy (LLLT) is a nonthermal approach to fat reduction and the proposed mechanism of action is the induction of a transitory pore into an adipocyte resulting in release of lipids and adipocyte deflation.

References:
  • 1. Fatemi A. High-intensity focused ultrasound effectively reduces adipose tissue. Semin Cutan Med Surg 2009;28(4):
  • 257–262
Question 6 of 10 HIGH-INTENSITY FOCUSED ULTRASOUND FOR FAT REDUCTION
A female patient makes contact with your office to find out more about HIFU to address trunk fat excess. Which one of the following should you tell her?
A
There is currently no strong evidence to support its use.
B
The ideal candidate has a body mass index (BMI) of 30 to 35.
C
It is not indicated for use on the trunk.
D
Treatment usually takes around 90 minutes to perform.
E
Results are not usually observed until 2 to 3 months.
āœ“ Correct Answer: E. Results are not usually observed until 2 to 3 months.
Clinical Explanation

HIFU is a noninvasive treatment used to reduce fat in specific body areas. It is indicated for waist circumference reduction and the ideal candidate is someone with a body mass index less than 30 and more than 2.5 cm of tissue on caliper pinch. There is a reasonable body of evidence to support its use. Two case series have been reported of 282 and 85 patients treated with HIFU to the abdomen and flank resulting in an average waist circumference decrease of 4.4 and 4.7 cm, respectively.1,2 A multicenter, randomized, sham-controlled, single-blinded trial of 180 patients studying HIFU in trunk aesthetics showed a decrease of 2.5 cm in the treatment group (single treatment) 1142 Part VII ā–  Aesthetic Surgery compared with 1.2 cm in the sham group.3 A multicenter, randomized, nonblinded study of 118 patients treated with a single HIFU treatment to the abdomen resulted in a decrease of 2.3 cm in waist circumference.4 The results are typically seen between 8 and 12 weeks posttreatment, so it is important to convey this information to patients prior to treatment to help set realistic expectations. The actual treatment involves marking the areas with the patient standing, followed by treatment delivery with the patient supine. Topical anesthetic is applied to the treatment areas. Multiple passes are made with the HIFU transducer to deliver the appropriate amount of energy, with the treatment usually being completed in less than an hour.

References:
  • 1. Fatemi A. High-intensity focused ultrasound effectively reduces adipose tissue. Semin Cutan Med Surg 2009;28(4):
  • 257–262
  • 2. Fatemi A, Kane MA. High-intensity focused ultrasound effectively reduces waist circumference by ablating adipose
  • tissue from the abdomen and flanks: a retrospective case series. Aesthetic Plast Surg 2010;34(5):577–582
  • 3. Jewell ML, Baxter RA, Cox SE, et al. Randomized sham-controlled trial to evaluate the safety and effectiveness of a
  • high-intensity focused ultrasound device for noninvasive body sculpting. Plast Reconstr Surg 2011;128(1):253–262
  • 4. Robinson DM, Kaminer MS, Baumann L, et al. High-intensity focused ultrasound for the reduction of subcutaneous
  • adipose tissue using multiple treatment techniques. Dermatol Surg 2014;40(6):641–651
Question 7 of 10 LOW-LEVEL LASER THERAPY FOR FAT REDUCTION
Which one of the following should you advise a female patient who is considering LLLT for targeted fat treatment?
A
She should expect a localized mild warming sensation during treatment.
B
She should expect erythema that persists for up to a month after treatment.
C
That following treatment, dressings will be applied for 2 weeks.
D
Pain control will require opiate medication for 48 hours after treatment.
E
That six consecutive monthly treatments will most likely be required.
āœ“ Correct Answer: A. She should expect a localized mild warming sensation during treatment.
Clinical Explanation

LLLT is a noninvasive, nonthermal approach to fat reduction performed with a laser wavelength of 635 nm. The proposed mechanism is mechanical disruption of the adipocyte leading to adipocyte deflation. Treatment involves transdermal delivery of the 635-nm laser which can cause a warming sensation during the procedure. Posttreatment erythema does occur but resolves within 24 hours. No dressings are required following this treatment. Multiple treatments will be required, but these are more frequent than monthly. Studies have reported outcomes after six treatments over 2 weeks or six consecutive weekly treatments. with good results.1–3 LLLT is not a particularly painful procedure, so opiate medications are not required. More simple oral and topical analgesia should suffice. Moreover, opiate analgesics should be avoided where possible due to their addictive nature.

References:
  • 1. Jackson RF, Stern FA, Neira R, Ortiz-Neira CL, Maloney J. Application of low-level laser therapy for noninvasive body
  • contouring. Lasers Surg Med 2012;44(3):211–217
  • 2. Nestor MS, Zarraga MB, Park H. Effect of 635 nm low-level laser therapy on upper arm circumference reduction. J Clin
  • Aesthet Dermatol 2012;5(2):42–48
  • 3. Thornfeldt CR, Thaxton PM, Hornfeldt CS. A six-week low-level laser therapy protocol is effective for reducing waist,
  • hip, thigh, and upper abdomen circumference. J Clin Aesthet Dermatol 2016;9(6):31–35
Question 8 of 10 LOW-LEVEL LASER THERAPY FOR FAT REDUCTION
You see a patient in the office who has recently undergone fat treatment to the abdomen with LLLT at a local aesthetic center. The patient is usually in good health, but now has areas of skin ulceration at the treatment sites. Which one of the following would be most likely to explain this?
A
Poor patient selection
B
Treatment at a setting too high
C
Treatment continued for longer than advised
D
Incorrect positioning of the laser diode panel
E
Failure to adequately dress the wound posttreatment
āœ“ Correct Answer: D. Incorrect positioning of the laser diode panel
Clinical Explanation

LLLT is indicated for circumference reduction of the upper arms, waist, hips, and thighs secondary to localized fat deposits. It involves the application of a laser device at 635 nm to target the subcutaneous tissues. The patient is marked standing then placed supine on the treatment table, exposing the area or areas to be treated. Laser diode modules are suspended ~15 cm above the anterior and then the posterior aspect of the treatment area and transdermal delivery of the 635 nm laser can commence. Specific distances, wattage, wavelength, and delivery duration vary depending on the device used. Complications are rare when the laser diode panel is appropriately placed; however, when it is applied directly to the skin, persistent erythema and skin ulceration may occur.1 This technical error is most likely to have occurred in this case and should be managed according to the principles of good wound care combined with an open and honest discussion with the patient. Patient selection is unlikely to be a cause of this problem unless they have a specific skin disorder. Contraindications otherwise are pregnancy, cancer, and large volume weight loss in obese patients. Too lengthy a treatment is also unlikely to cause this if the diode is correctly placed. No dressings are normally required after treatment, although they may be applied for patient comfort if desired.

References:
  • 1. Jankowski M, Gawrych M, Adamska U, Ciescinski J, Serafin Z, Czajkowski R. Low-level laser therapy (LLLT) does not reduce
  • subcutaneous adipose tissue by local adipocyte injury but rather by modulation of systemic lipid metabolism. Lasers
  • Med Sci 2017;32(2):475–479
Question 9 of 10 PARADOXICAL ADIPOSE HYPERPLASIA
Which one of the following is optimal to treat a patient with paradoxical adipose tissue hyperplasia to the abdomen?
A
Cryolipolysis
B
HIFU
C
LLLT
D
Liposuction
E
No treatment is usually required
āœ“ Correct Answer: D. Liposuction
Clinical Explanation

abdomen? Paradoxical adipose hyperplasia (PAH) is a condition where instead of reducing fat by performing noninvasive fat reduction, a process of hyperplasia ensures, leading to an increase in tissue firmness and fullness. PAH is specifically associated with cryolipolysis and has an incidence of just less than 1%.1,2 When it does occur, it is unlikely to resolve spontaneously, and patients require an additional procedure to correct this. The primary treatment modality would be liposuction, although excisional surgery such as an abdominoplasty may also be considered. The main challenges of managing patients with PAH therefore are not only that they are in a worse position than when they started and will need some further surgical intervention, but they must also wait a number of months for the tissues to soften before any revision treatment can be undertaken. This would normally be at 6 to 9 months. The risk factors for developing PAH include male gender, Hispanic ethnicity, use of a large hand piece, and genetic predisposition.1–3

References:
  • 1. Karcher C, Katz B, Sadick N. Paradoxical hyperplasia post-cryolipolysis and management. Dermatol Surg 2017;43(3):
  • 467–470
  • 2. Kelly E, Rodriguez-Feliz J, Kelly ME. Paradoxical adipose hyperplasia after cryolipolysis: a report on incidence and com-
  • mon factors identified in 510 patients. Plast Reconstr Surg 2016;137(3):639e–640e
  • 3. Stroumza N, Gauthier N, Senet P, Moguelet P, Nail Barthelemy R, Atlan M. Paradoxical adipose hypertrophy (PAH) after
  • cryolipolysis. Aesthet Surg J 2018;38(4):411–417
Question 10 of 10 CONTRAINDICATIONS TO NONINVASIVE BODY CONTOURING
Which one of the following is a contraindication to all of the main noninvasive fat therapies?
A
Patients with cold urticaria
B
Patients with mild skin laxity
C
Patients older than 55 years
D
Patients who are pregnant
E
Patients who are fit for liposuction
āœ“ Correct Answer: D. Patients who are pregnant
Clinical Explanation

There are a number of contraindications to using noninvasive body contouring techniques. Pregnancy is a contraindication across the board for all treatments. Cold urticarial is a contraindication specific to cryolipolysis. Mild skin laxity is not a contraindication to treatment, as a mild skin tightening effect can often be seen as a secondary benefit of these procedures. However, greater amounts of skin laxity are a contraindication to noninvasive treatments because the skin will not retract well following the procedure, leading to a compromised aesthetic result. Age is not a contraindication to any of the treatment modalities for noninvasive fat reduction. Liposuction is a useful surgical intervention for managing specific fat deposits, but it should not always be the first-line choice for every patient. Even if a patient is healthy enough and agreeable to undergo liposuction, if they may benefit from a noninvasive approach this should be considered first.1–3

References:
  • 1. Ingargiola MJ, Motakef S, Chung MT, Vasconez HC, Sasaki GH. Cryolipolysis for fat reduction and body contouring: safety
  • and efficacy of current treatment paradigms. Plast Reconstr Surg 2015;135(6):1581–1590
  • 2. Manstein D, Laubach H, Watanabe K, Farinelli W, Zurakowski D, Anderson RR. Selective cryolysis: a novel method of
  • non-invasive fat removal. Lasers Surg Med 2008;40(9):595–604
  • 3. Alizadeh Z, Halabchi F, Mazaheri R, Abolhasani M, Tabesh M. Review of the mechanisms and effects of noninvasive body
  • contouring devices on cellulite and subcutaneous fat. Int J Endocrinol Metab 2016;14(4):e36727

šŸŽ‰ Chapter Completed!

Back to All Chapters